XML 186 R109.htm IDEA: XBRL DOCUMENT v3.26.1
Discontinued operations - Cash flows (used in)/from discontinued operation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure of analysis of single amount of discontinued operations [line items]      
Net cash from/(used in) operating activities $ 49 $ 5,563 $ (11,420)
Net cash used in investing activities (3,539) (318) (404)
Net cash used in financing activities (961) (1,413) (2,653)
Net cash (outflows)/inflows for the year (4,451) 3,832 (14,477)
Prevention and diagnostics - COVID-19 related and EMEA operations      
Disclosure of analysis of single amount of discontinued operations [line items]      
Net cash from/(used in) operating activities 3,585 80 (901)
Net cash used in investing activities (3,301) 0 119
Net cash used in financing activities 0 0 (1,184)
Net cash (outflows)/inflows for the year 284 80 (1,966)
ACT genomics      
Disclosure of analysis of single amount of discontinued operations [line items]      
Net cash from/(used in) operating activities (3,536) 5,483 (10,519)
Net cash used in investing activities (238) (318) (523)
Net cash used in financing activities (961) (1,413) (1,469)
Net cash (outflows)/inflows for the year $ (4,735) $ 3,752 $ (12,511)